Corticotropin-Releasing Factor receptor 1 (CRF1) antagonism in patients with alcohol use disorder and high anxiety levels: effect on neural response during Trier Social Stress Test video feedback-Reference-Cited by-同舟云学术

Corticotropin-Releasing Factor receptor 1 (CRF1) antagonism in patients with alcohol use disorder and high anxiety levels: effect on neural response during Trier Social Stress Test video feedback

Published:2022-12-23 Issue:5 Volume:48 Page:816-820
ISSN:0893-133X
Container-title:Neuropsychopharmacology
language:en
Short-container-title:Neuropsychopharmacol.

Author:

Lee Mary R.,Rio Daniel,Kwako Laura^ORCID,George David T.,Heilig Markus,Momenan Reza^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Pharmacology

Link

https://www.nature.com/articles/s41386-022-01521-z.pdf

Reference37 articles.

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric Pub; 2013.

2. Sanford CA, Soden ME, Baird MA, Miller SM, Schulkin J, Palmiter RD, et al. A central amygdala CRF circuit facilitates learning about weak threats. Neuron. 2017;93:164–78.

3. Heilig M, Koob GF. A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci. 2007;30:399–406.

4. Zorrilla EP, Heilig M, de Wit H, Shaham Y. Behavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism. Drug Alcohol Depend. 2013;128:175–86.

5. Binneman B, Feltner D, Kolluri S, Shi Y, Qiu R, Stiger T. A 6-week randomized, placebo-controlled trial of CP-316,311 (a selective CRH 1 antagonist) in the treatment of major depression. Am J Psychiatry. 2008;165:617–20.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Central amygdala CRF1 cells control nociception and anxiety-like behavior;Neuropsychopharmacology;2023-08-05

2. Neuroscience targets and human studies: future translational efforts in the stress system;Neuropsychopharmacology;2023-02-01